1. Home
  2. CDLR vs SDGR Comparison

CDLR vs SDGR Comparison

Compare CDLR & SDGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cadeler AS

CDLR

Cadeler AS

HOLD

Current Price

$20.35

Market Cap

1.5B

Sector

N/A

ML Signal

HOLD

Logo Schrodinger Inc.

SDGR

Schrodinger Inc.

HOLD

Current Price

$18.68

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CDLR
SDGR
Founded
2008
1990
Country
Denmark
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.3B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
CDLR
SDGR
Price
$20.35
$18.68
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
$25.33
AVG Volume (30 Days)
131.5K
860.1K
Earning Date
11-20-2025
02-25-2026
Dividend Yield
N/A
N/A
EPS Growth
2505.89
N/A
EPS
0.90
N/A
Revenue
$632,099,026.00
$256,951,000.00
Revenue This Year
$144.16
$23.69
Revenue Next Year
$69.44
$20.46
P/E Ratio
$5.53
N/A
Revenue Growth
198.94
32.90
52 Week Low
$15.37
$15.99
52 Week High
$23.05
$28.47

Technical Indicators

Market Signals
Indicator
CDLR
SDGR
Relative Strength Index (RSI) 68.15 55.04
Support Level $18.81 $17.50
Resistance Level $19.23 $19.58
Average True Range (ATR) 0.37 0.68
MACD 0.15 0.10
Stochastic Oscillator 98.44 63.67

Price Performance

Historical Comparison
CDLR
SDGR

About CDLR Cadeler AS

Cadeler AS is an offshore wind farm vessel contractor. It is engaged in offshore wind farm construction, maintenance, and decommissioning and provides marine and engineering operations to the wind industry, focusing on safety and the environment. The company operates six offshore jack-up wind farm installation vessels. In addition to wind farm installation, these vessels can perform maintenance, construction, decommissioning, and other tasks within the offshore industry.

About SDGR Schrodinger Inc.

Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.

Share on Social Networks: